Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

BRAF

Protein in a cell that participates in cell division processes and is also an oncogen. BRAF mutations appear in different cancers. The drugs and Moraphenib (generic name: Vemurafenib, trade name: Zelboraf®) and Debrafenib (generic name: Tafinlar®) are given to patients with mutations in BRAF.

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics